What are Viridian Therapeutics, Inc.'s profit margins?

Gross margin is 36.3% and operating margin is -543.9%, with a -508.5% net margin.

Where does Viridian Therapeutics, Inc.'s income statement data come from?

Every line is extracted from Viridian Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Viridian Therapeutics, Inc. VRDN Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$70.92M+0.1%	$70.85M+0.1%	$70.79M+23,110%	$305K+1.0%	$302K0.0%
Research and development	$339.73M+0.2%	$338.93M+5.4%	$321.68M+5.6%	$304.58M+11.1%	$274.15M+15.1%
Selling, general and administrative	——	——	——	——	$62.92M+3.0%
Total operating expenses	$456.62M+5.2%	$434.24M+8.9%	$398.91M+7.3%	$371.89M+10.3%	$337.31M+12.7%
Operating income	-$385.7M-6.1%	-$363.4M-10.8%	-$328.12M+11.7%	-$371.59M-10.3%	-$337.01M-12.7%
Operating margin	-543.9%-30.9pp	-512.9%-49.4pp	-463.5%+121,368pp	-121,831.1%-10,240pp	-111,591.1%-12,573pp
Interest expense	$7.82M+59.4%	$4.91M+129%	$2.14M+1.5%	$2.11M-3.8%	$2.19M-1.7%
Other income (expense), net	$25.11M+20.7%	$20.79M-20.5%	$26.15M-5.0%	$27.52M-4.1%	$28.69M-1.4%
Net income	-$360.59M-5.3%	-$342.6M-13.5%	-$301.97M+12.2%	-$344.06M-11.6%	-$308.32M-14.2%
Net margin	-508.5%-24.9pp	-483.6%-57.0pp	-426.6%+112,380pp	-112,806.9%-10,715pp	-102,092.4%-12,705pp
Diluted earnings per share	——	——	——	——	——
EBITDA	-$385.23M-6.1%	-$362.94M-10.8%	-$327.66M+11.7%	-$371.1M-10.3%	-$336.49M-12.7%
EBITDA margin	-543.2%-30.9pp	-512.3%-49.4pp	-462.9%+121,210pp	-121,672.8%-10,251pp	-111,421.5%-12,582pp
EBIT	-$385.7M-6.1%	-$363.4M-10.8%	-$328.12M+11.7%	-$371.59M-10.3%	-$337.01M-12.7%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Viridian Therapeutics, Inc.'s profit margins?: Gross margin is 36.3% and operating margin is -543.9%, with a -508.5% net margin.
Where does Viridian Therapeutics, Inc.'s income statement data come from?: Every line is extracted from Viridian Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.